CAPRICOR THERAPEUTICS, INC. — Form D

CAPRICOR THERAPEUTICS, INC. of BEVERLY HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-27. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Arie S BelldegrunDirectorNew York, NY
Richard B BrewerDirectorBroomfield, CO
Pedro S GranadilloDirectorSan Mateo, CA
Peter M KashDirectorSan Mateo, CA
Joshua A KazamDirectorSan Mateo, CA
Frank M LitvackDirectorPalo Alto, CA
Paul A MieyalDirectorLouisville, CO
Gregory W SchaferDirectorBerkeley, CA
Richard B BrewerExecutive OfficerBroomfield, CO
Daron A EvansExecutive OfficerSan Mateo, CA
Joshua A KazamExecutive OfficerSan Mateo, CA
Hsiao D LieuExecutive OfficerSouth San Francisco, CA
Andrew HamerExecutive OfficerOakville, A6
Joshua KazamDirectorNew York, NY
David M TanenDirectorNew York, NY
David M TanenExecutive OfficerNew York, NY
George DunbarDirectorAnn Arbor, MI
Daron EvansExecutive OfficerSouth Orange, NJ
Frank LitvackDirectorMENLO PARK, CA
Deborah AscheimExecutive OfficerBEVERLY HILLS, CA
Leland GershellExecutive OfficerBEVERLY HILLS, CA
Earl CollierDirectorBEVERLY HILLS, CA
Louis ManzoDirectorBEVERLY HILLS, CA
Rachel SmithExecutive OfficerBEVERLY HILLS, CA
Karen KrasneyExecutive OfficerBEVERLY HILLS, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2017-05-19D$3.7M$3.7M
2016-03-29D$14K$14K
2015-02-19D$7.1M$7.1M
2015-02-03D$10.0M$10.0M
2014-02-24D$33K$33K
2013-12-05D$26.3M$26.3M
2009-07-15D$3.0M$2.3M

More